Welcome!

News Feed Item

US Personalized Cancer Genome Sequencing Market Outlook 2018

NEW YORK, March 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

US Personalized Cancer Genome Sequencing Market Outlook 2018
http://www.reportlinker.com/p02048459/US-Personalized-Cancer-Genome-Sequencing-Market-Outlook-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

The whole genome sequencing technology, over the past decade, has developed at an unprecedented rate. There has been a rapid progression from targeted gene sequencing to targeted whole genome sequencing coupled with bioinformatics based sequencing platforms to analyze the data and thereby impart personalized treatment to individuals. The Whole Genome Sequencing has proved to be a key to new breakthrough in fighting against cancer. The explosion of genomic data into personalized treatment of cancer is due to the development of new methods, and the exponential decline in cost of whole genome sequencing.

Our report entitled "US Personalized Cancer Genome Sequencing Market Outlook 2018" entails detailed study of current and future cancer prevalence and incidences across US. In addition, it provides an insight about the leading states with cancer incidences. Also covered is age wise statistics for cancer and comprehensive figures for cancer in males and females. Further, we have provided potential states for whole genome sequencing to help market players gauge maximum opportunity for growth. Besides, the report also provides potential customer base and the market's growth potential for personalized cancer WGS till 2018.

The said advanced technology has potential to revolutionize the field of medicine. We have closely monitored the regulatory landscape related to sequencing which requires consideration of the authorities over genome based tests. It has been observed that whole genome sequencing services have been concurrently regulated by FDA, CDC and CMS. Further, we have also discussed the various constraints faced by the industry players with suitable suggestions to overcome them. Apart from this, a major hurdle is to persuade health insurers to reimburse for the cost of sequencing the genomes of individual.

The report analyzes the competitive landscape of the market by properly analyzing the business, services and activities of the companies such as Illumina, Complete Genomics, and Ambry Genetics. It also provides the competitive benchmarking, taking into account key information such as market value, revenues, risk score etc., along with the strengths and weaknesses of each player. Overall, the report is a complete source of knowledge and statistics for clients who want to get an in-depth understanding of the market.
1. Analyst View
2. Research Methodology
3. Genome Sequencing: An Introduction
4. Cancer Statistics by Demographics
4.1 Prevalence, Incidences, and Mortality (2010-2018)
4.2 Leading States by Incidence
4.3 Leading Cancers by Incidence
4.3.1 Male Cancer Incidences
4.3.2 Female Cancer Incidences
4.3.3 Age-Group
5. US Personalized Cancer WGS Potential Market to 2018
6. US Personalized Cancer WGS: Current and Future Market Analysis
7. Regulatory Insights
7.1 Clinical Laboratory Improvement Amendments (CLIA) Accreditation
7.2 CAP Accreditation
8. Market Constraints
9. Competitive Assessment
9.1 Illumina
9.1.1 Business Overview
9.1.2 Key Information
9.1.3 Strengths and Weaknesses
9.2 Complete Genomics
9.2.1 Business Overview
9.2.2 Key Information
9.2.3 Strengths and Weaknesses
9.3 Beckman Coulter Genomics
9.3.1 Business Overview
9.3.2 Key Information
9.3.3 Strengths and Weaknesses
9.4 Expression Analysis
9.4.1 Business Overview
9.4.2 Key Information
9.4.3 Strengths and Weaknesses
9.5 EdgeBio
9.5.1 Business Overview
9.5.2 Key Information
9.5.3 Strengths and Weaknesses
9.6 Foundation Medicine
9.6.1 Business Overview
9.6.2 Key Information
9.6.3 Strengths and Weaknesses
9.7 SeqWright
9.7.1 Business Overview
9.7.2 Key Information
9.7.3 Strengths and Weaknesses
9.8 Ambry Genetics
9.8.1 Business Overview
9.8.2 Key Information
9.8.3 Strengths and Weaknesses
9.9 BGI Americas Corporation
9.9.1 Business Overview
9.9.2 Key Information
9.9.3 Strengths and Weaknesses
9.10 Cofactor Genomics
9.10.1 Business Overview
9.10.2 Key Information
9.10.3 Strengths and Weaknesses

List of Figures:

Figure 3-1: Schematic Diagram of Sequencing used for Human Genome Project
Figure 3-2: Long-range Sequence Assembly in Whole Genome Shotgun Sequencing
Figure 4-1: Cancer Prevalence (Million), 2010-2018
Figure 4-2: Cancer Incidences (Million), 2010-2018
Figure 4-3: Cancer Mortality ('000), 2010-2018
Figure 4-4: Incidences by Type of Cancer (%), 2014
Figure 4-5: Cancer Incidences by Age Group (%), 2010
Figure 5-1: Number of People earning > US$ 100K (2009-2012)
Figure 5-2: Potential Customers for Personalized Cancer WGS Market (Billion), 2013-2018
Figure 5-3: Potential Customers for Personalized Cancer WGS Market by Age-Group (%), 2014
Figure 5-4: Potential Market for Personalized Cancer WGS (Billion US$), 2013-2018
Figure 6-1: Tapped and Untapped Personalized Cancer WGS Market (%), 2014
Figure 6-2: Personalized Cancer WGS Market (Million US$), 2013-2018

List of Tables:

Table 4-1: Top Ten States with Highest Cancer Incidences ('000), 2014
Table 4-2: Top Ten Cancer Incidences in Males (2014)
Table 4-3: Top Ten Cancer Incidences in Females (2014)
Table 5-1: Top Ten States with Households earning > US$ 100K (2012)
Table 5-2: Key Demographics and Potential Customers for Personalized Cancer WGS Market (2014)
Table 5-3: Potential States for Personalized Cancer Whole Genome Sequencing
Table 9-1: Illumina - Key information
Table 9-2: Complete Genomics - Key Information
Table 9-3: Beckman Coulter Genomics - Key Information
Table 9-4: Expression Analysis - Key Information
Table 9-5: Edge Bio - Key Information
Table 9-6: Foundation Medicine - Key Information
Table 9-7: SeqWright - Key Information
Table 9-8: Ambry Genetics - Key Information
Table 9-9: BGI Americas Corporation - Key Information
Table 9-10: Cofactor Genomics - Key Information

To order this report: US Personalized Cancer Genome Sequencing Market Outlook 2018
http://www.reportlinker.com/p02048459/US-Personalized-Cancer-Genome-Sequencing-Market-Outlook-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
After more than five years of DevOps, definitions are evolving, boundaries are expanding, ‘unicorns’ are no longer rare, enterprises are on board, and pundits are moving on. Can we now look at an evolution of DevOps? Should we? Is the foundation of DevOps ‘done’, or is there still too much left to do? What is mature, and what is still missing? What does the next 5 years of DevOps look like? In this Power Panel at DevOps Summit, moderated by DevOps Summit Conference Chair Andi Mann, panelists loo...
Automation is enabling enterprises to design, deploy, and manage more complex, hybrid cloud environments. Yet the people who manage these environments must be trained in and understanding these environments better than ever before. A new era of analytics and cognitive computing is adding intelligence, but also more complexity, to these cloud environments. How smart is your cloud? How smart should it be? In this power panel at 20th Cloud Expo, moderated by Conference Chair Roger Strukhoff, paneli...
"Loom is applying artificial intelligence and machine learning into the entire log analysis process, from start to finish and at the end you will get a human touch,” explained Sabo Taylor Diab, Vice President, Marketing at Loom Systems, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
A look across the tech landscape at the disruptive technologies that are increasing in prominence and speculate as to which will be most impactful for communications – namely, AI and Cloud Computing. In his session at 20th Cloud Expo, Curtis Peterson, VP of Operations at RingCentral, highlighted the current challenges of these transformative technologies and shared strategies for preparing your organization for these changes. This “view from the top” outlined the latest trends and developments i...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
@DevOpsSummit at Cloud Expo taking place Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center, Santa Clara, CA, is co-located with the 21st International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is ...
"We are a monitoring company. We work with Salesforce, BBC, and quite a few other big logos. We basically provide monitoring for them, structure for their cloud services and we fit into the DevOps world" explained David Gildeh, Co-founder and CEO of Outlyer, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Join us at Cloud Expo June 6-8 to find out how to securely connect your cloud app to any cloud or on-premises data source – without complex firewall changes. More users are demanding access to on-premises data from their cloud applications. It’s no longer a “nice-to-have” but an important differentiator that drives competitive advantages. It’s the new “must have” in the hybrid era. Users want capabilities that give them a unified view of the data to get closer to customers and grow business. The...
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
Artificial intelligence, machine learning, neural networks. We’re in the midst of a wave of excitement around AI such as hasn’t been seen for a few decades. But those previous periods of inflated expectations led to troughs of disappointment. Will this time be different? Most likely. Applications of AI such as predictive analytics are already decreasing costs and improving reliability of industrial machinery. Furthermore, the funding and research going into AI now comes from a wide range of com...
"When we talk about cloud without compromise what we're talking about is that when people think about 'I need the flexibility of the cloud' - it's the ability to create applications and run them in a cloud environment that's far more flexible,” explained Matthew Finnie, CTO of Interoute, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...